{"title":"Internet-delivered acceptance and commitment therapy for COVID-19 related health anxiety: a pragmatic study.","authors":"Ditte Hoffmann Frydendal, Katrine Ingeman, Per Klausen Fink, Kaare Bro Wellnitz, Lisbeth Frostholm","doi":"10.1080/08039488.2025.2506560","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Health anxiety (HA) is characterized by excessive worries about having a serious illness, persisting even after medical reassurance. The COVID-19 pandemic, with widespread media coverage and lockdowns, may induce or exacerbate HA. During a pandemic, treatment options can be limited by lockdowns and social distancing, making remote, internet-delivered therapies particularly useful for individuals isolating due to health worries. This study aimed to assess the effectiveness of an internet-delivered Acceptance and Commitment Therapy (iACT) for COVID-19-related HA.</p><p><strong>Methods: </strong>In a Danish university hospital, an uncontrolled national implementation project was conducted. Patients self-referred were assessed <i>via</i> video, and those eligible (≥18 years) received 12 weeks of iACT. The primary outcome was HA symptoms measured by the Whiteley-6-R Index. Secondary outcomes included somatic symptoms, depression, anxiety, quality of life, and life satisfaction. Changes from baseline to post-treatment were analyzed using paired t-tests and Cohen's d for effect size.</p><p><strong>Results: </strong>Out of 223 screened patients, 105 were eligible for enrollment, and 67 responded to post-treatment questionnaires. Significant improvements were observed across all outcomes, particularly for HA (<i>d</i> = 1.40) and anxiety (<i>d</i> = 0.80), along with better quality of life (<i>d</i> = 0.65) and life satisfaction (<i>d</i> = 0.64).</p><p><strong>Conclusions: </strong>Implementation of self-referral and internet-delivered treatment into routine care was feasible and seemed to be effective in treating COVID-19-related HA. However, for self-referred participants, the poor eligibility and motivation may be a limitation when implementing this online treatment during a pandemic. In addition, collecting data in routine care may be a challenge.</p><p><strong>Trial registry numbers: </strong>Approved by the Danish Data Protection Agency (ID no. 790861).</p>","PeriodicalId":19201,"journal":{"name":"Nordic Journal of Psychiatry","volume":" ","pages":"1-7"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nordic Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08039488.2025.2506560","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Health anxiety (HA) is characterized by excessive worries about having a serious illness, persisting even after medical reassurance. The COVID-19 pandemic, with widespread media coverage and lockdowns, may induce or exacerbate HA. During a pandemic, treatment options can be limited by lockdowns and social distancing, making remote, internet-delivered therapies particularly useful for individuals isolating due to health worries. This study aimed to assess the effectiveness of an internet-delivered Acceptance and Commitment Therapy (iACT) for COVID-19-related HA.
Methods: In a Danish university hospital, an uncontrolled national implementation project was conducted. Patients self-referred were assessed via video, and those eligible (≥18 years) received 12 weeks of iACT. The primary outcome was HA symptoms measured by the Whiteley-6-R Index. Secondary outcomes included somatic symptoms, depression, anxiety, quality of life, and life satisfaction. Changes from baseline to post-treatment were analyzed using paired t-tests and Cohen's d for effect size.
Results: Out of 223 screened patients, 105 were eligible for enrollment, and 67 responded to post-treatment questionnaires. Significant improvements were observed across all outcomes, particularly for HA (d = 1.40) and anxiety (d = 0.80), along with better quality of life (d = 0.65) and life satisfaction (d = 0.64).
Conclusions: Implementation of self-referral and internet-delivered treatment into routine care was feasible and seemed to be effective in treating COVID-19-related HA. However, for self-referred participants, the poor eligibility and motivation may be a limitation when implementing this online treatment during a pandemic. In addition, collecting data in routine care may be a challenge.
Trial registry numbers: Approved by the Danish Data Protection Agency (ID no. 790861).
期刊介绍:
Nordic Journal of Psychiatry publishes international research on all areas of psychiatry.
Nordic Journal of Psychiatry is the official journal for the eight psychiatry associations in the Nordic and Baltic countries. The journal aims to provide a leading international forum for high quality research on all themes of psychiatry including:
Child psychiatry
Adult psychiatry
Psychotherapy
Pharmacotherapy
Social psychiatry
Psychosomatic medicine
Nordic Journal of Psychiatry accepts original research articles, review articles, brief reports, editorials and letters to the editor.